Cell and gene therapy CRO market Growth Opportunity and Industry Forecast to 2035 Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell and Gene Therapy CROs Market, 2022-2035”. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:  A detailed overview of the overall market landscape of the cell and gene therapy CROs, based on several relevant parameters, such as year of establishment, company size, location of headquarters, area of expertise, scale of operation and types of services offered.  A detailed analysis on the business models that are commonly adopted by the biopharmaceutical industry for outsourcing cell and gene therapies.  Elaborate profiles of key industry players based in North America, Europe and Asia-Pacific that offer contract research services.  A benchmark analysis of the various players engaged in this domain. It highlights the capabilities of the companies.  An analysis of the recent collaborations within the cell and gene therapy contract research industry, during the period 2015-2022.  A detailed analysis of the various mergers and acquisitions that have taken place in this domain, during the period 2015-2022.  A detailed acquisition target analysis, taking into consideration historical trend of the activity of players that have acquired other firms since 2015.  A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution highlighting the relative effect of each SWOT parameter on the overall cell and gene therapies research services industry.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Area of Expertise  Cell Therapy  Gene Therapy  Scale of Operation  Preclinical  Clinical  Drug Discovery  Therapeutic Area  Oncological Disorders  Neurological Disorders  Cardiovascular Disorders  Infectious Diseases  Metabolic Disorders  Autoimmune Disorders  Blood Disorders  Rare / Genetic Disorders  Ophthalmic Disorders  Other disorders  Analysis by Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa Key companies covered in the report  Altasciences  Charles River Laboratories  Creative Biolabs  IQVIA  Medpace  PPD  Precision for Medicine  Accelera  Evotec  ICON  Syneos Health  CMIC Group  Labcorp To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html News article AI-based digital pathology market Learn from experts: do you know about these emerging industry trends? TCR Therapies: An Emerging Therapeutic Modality Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #atmps #genetherapycro #cellandgenetherapycompanies #MarketResearch #MarketInsights

Cannabis Testing market Trends, Analysis by 2035 The legalization and recent applications of cannabis for the treatment of certain medical conditions has led to the rise in demand for various cannabis-infused products. These products need to be tested thoroughly, in order to maintain regulatory standards and ensure consumer safety. Following this, cannabis testing services are currently being used across several industries, including healthcare, chemical, cosmetic, agriculture and food. The financial opportunity within the cannabis testing market has been analyzed across the following segments:  Type of Cannabis Tested  Medical Cannabis  Recreational / Adult-use Cannabis  Type of Sample Tested  Flowers  Extracts  Edibles  Others  Company Size  Large  Mid-sized  Small  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa The research also includes profiles of key players (listed below) engaged in the cannabis testing market; each profile features a brief overview of the company, details related to its financial information (if available), service portfolio, recent developments, and an informed future outlook.  AccuScience Laboratories  Anresco Labs  CDX Analytics  Coastal Analytical  Eurofins Scientific  EVIO Labs  FoodChain ID  LGC  Medicine Creek Analytics  SGS  Tentamus Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape: Cannabis Testing Service Providers 5. Cannabis Testing Service Providers: Company Competitiveness Analysis 6. Cannabis Testing Service Providers: Company Profiles 7. Market Landscape: Cannabis Testing Product Providers 8. Partnerships and Collaborations 9. Global Event Analysis 10. Cannabis Testing Services Market: Market Sizing and Opportunity Analysis 11. Concluding Remarks 12. Executive Insights 13. Appendix 1: Tabulated Data 14. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/cannabis-testing-market.html News article Non-viral Transfection Reagents and Systems Market Learn from experts: do you know about these emerging industry trends? mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends Novel Cell Cytometers: Need of the Hour Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com #cannabistesting #cannabistestingservicesmarket #medicalcannabistesting #MarketResearch #MarketInsights

Cell Free Expression market Size, Share, Trends by 2035 The growing pipeline of biologics and challenges associated with their manufacturing have prompted stakeholders in the biopharmaceutical industry to adopt cell free expression systems for effective synthesis of biotherapeutics Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Free System: Cell Free Expression Kits and Service Providers, 2023-2035.” The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different regions. Amongst other elements, the research report includes:  An executive summary of insights captured during our research.  A general overview of cell free systems, the different types of such systems and their composition. It provides a brief outline of the cell free expression process, highlighting several challenges and advantages associated with this technique  A detailed assessment of the current market landscape of cell free expression service providers.  A detailed assessment of the current market landscape of cell free expression kits, based on several relevant parameters.  A comprehensive company competitiveness analysis of cell free expression service providers.  A product competitiveness analysis of cell free expression kits based on various relevant parameters.  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering cell free expression services.  Elaborate profiles of prominent players engaged in development of cell free expression kits (shortlisted based on a proprietary criterion).  A detailed analysis of recent partnerships inked between stakeholders engaged in this industry, from 2018.  An analysis of the funding and investments made in the cell free expression market, since 2018.  An in-depth analysis of various patents that have been filed / granted related to cell free system since 2015.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Cell Free System • Crude Cell Lysate-based Systems • Reconstituted Systems  Type of Host Organism • Microbial Cell Free Expression Systems • Mammalian Cell Free Expression Systems • Plant-based Cell Free Expression Systems • Other Cell Free Expression Systems  Type of Expression Method • Coupled Transcription and Translation Method • Translation Method  End-User • Pharmaceutical and Biotechnology Companies • Academic and Research Institutes • Other End-Users  Key Geographical Regions • North America • Europe • Asia Pacific • Rest of the World Key companies covered in the report  BioLinker  biotechrabbit  CellFree Sciences  Creative Biolabs  CUSABIO  Daicel Arbor Biosciences  LenioBio  Promega  Thermo Fisher Scientific  Touchlight For additional details, please visit https://www.rootsanalysis.com/reports/cell-free-expression-market.html News article Biopharmaceutical Filtration Market Learn from experts: do you know about these emerging industry trends? CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space Learn from our recently published whitepaper: - Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Cellfreeproteinsynthesis #cellfreeproteinsynthesis #cellfreesystem #MarketResearch #MarketInsights

mRNA therapeutics and Vaccines market, Size and Share by 2035 Characterized by a rapidly growing pipeline of products, the mRNA therapeutics and vaccines segment is anticipated to revolutionize the biopharmaceutical industry Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Therapeutics and mRNA Vaccines Market, 2022-2035”. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:  A detailed overview of the overall market landscape of mRNA therapeutics and vaccines, based on several relevant parameters.  A detailed overview of the current market of players engaged in the development of mRNA therapeutics and vaccines.  An in-depth company competitiveness analysis of mRNA therapeutics and vaccines developers based on their portfolio strength (in terms of year of establishment and company size), pipeline strength (in terms of its pipeline maturity and drug administration route) and number of therapeutic areas targeted.  Detailed profiles of marketed and late stage (phase III) mRNA therapeutics and mRNA vaccines.  A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021).  An analysis of start-ups (established between 2016-2022) engaged in this domain, based on several relevant parameters.  An analysis of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines, based on several relevant parameters.  An analysis of recent collaborations and partnerships within the mRNA therapeutics and vaccines industry.  A detailed analysis of various investments made by players engaged in this domain, during the period 2013-2022.  An in-depth analysis of the various patents that have been filed / granted related to mRNA therapeutics and vaccines domain, since 2016.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Routes of Administration  Intradermal  Intravenous  Intranasal  Others  Therapeutic Area  Infectious Diseases  Oncological Disorders  Other Disorders  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa Key companies covered in the report  Arcturus Therapeutics  BioNTech and Pfizer  CureVac  Gennova  Moderna  Walvax To view more details on this report, click on the link https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html News article Cell and Gene Therapy CROs Market Learn from experts: do you know about these emerging industry trends? Intracellular Drug Delivery – Future Potential Key Trends in Non-Viral Transfection Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #mrnatherapeuticscompanies #mrnavaccinecompanies #mrnatechnology #MarketResearch #MarketInsights

Dental 3D Printing market Research Report by 2023, Forecast till 2035 The popularity of 3D printing technology within the dental industry can be attributed to its ability to print high quality / accurate dental products, including crowns, bridges, dentures, dental implants and surgical guides. Driven by the overall growth of the additive manufacturing (3D printing) industry, and wide adoption of 3D printers in the dental sector, the dental 3D printing market is anticipated to witness a steady growth in the foreseen future. The financial opportunity within the SMOs market has been analyzed across the following segments:  Type of Printing Technology  VAT Polymerization Technology  Powder Bed Fusion Technology  Polyjet Technology  Metal Extrusion Technology  Other Technologies  Application Area  Prosthodontics  Orthodontics  Dental Implants  Other Applications  Type of Printing Material  Resins  Plastics  Metals  Metals  Other Material  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa  Rest of the World The Dental 3D Printing Market, 2022 – 2035 report studies dental 3D printers manufacturers in detail and features the following companies, which we identified to be key players in this domain:  3D Systems  Asiga  BEGO  Carbon  Digital Wax Systems (DWS)  Formlabs  Prodways  Rapid Shape  SprintRay  Stratasys Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Product Competitive Analysis 6. Company Profiles 7. Partnerships and Collaborations 8. Patent Analysis 9. Bowman Clock Pricing 10. Market Forecast and Opportunity Analysis 11. Concluding Remarks 12. Executive Insights 13. Appendix 1: Tabulated Data 14. Appendix 2: List of Companies And Organizations Get more details on the Dental 3D Printing Market report https://www.rootsanalysis.com/reports/dental-3d-printing-market.html You may also be interested in the following titles: Digital Biomanufacturing Market Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain Global Digital Therapeutics Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #dental3dprinting #dental3dprinter #dental3dprinters #MarketResearch #MarketInsights

Aseptic Fill Finish market Analysis and Trends by 2023-2035 In pursuit of both time and cost savings, as well as to mitigate the challenges associated with the stringent regulatory compliance, lack of technical expertise and access to advanced equipment, a number of drug developers prefer to outsource operations to benefit from the expertise of service providers, that claim to have the required competence and experience to provide fill / finish services in order to ensure the development of high-quality drug products. The financial opportunity within the aseptic fill finish services market has been analyzed across the following segments:  Type of Molecule  Small molecules  Biologics  Type of Packaging Container  Ampoules  Cartridges  Syringes  Vials  Type of Drug Product  Antibodies  Cell Therapies  Gene Therapies  Oligonucleotides  Recombinant Proteins  Vaccines  Other Drug Products  Target Therapeutic Area  Autoimmune disorders  Oncological Disorders  Cardiovascular Disorders  Infectious Diseases  Other Disorders  Scale Of Operation  Preclinical / Clinical  Commercial  Company Size  Large  Mid-sized  Small  Key Geographical Regions  North America  Europe  Asia-Pacific  Middle East and North Africa  Latin America The Aseptic Fill Finish Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:  BD Biosciences  AbbVie Contract Manufacturing  Aenova  APL  Asymchem  BD Biosciences  BioPharma Solutions  BioReliance  Boehringer Ingelheim BioXcellence  Catalent Biologics  Charles River Laboratories  CordenPharma  Delpharm  Fareva  Fresenius Kabi  GlaxoSmithKline  Hetero Drugs  Intas Pharmaceuticals  Lonza  Patheon  Pfizer CentreOne  Pierre Fabre  PiSA Farmaceutica  Plastikon Healthcare  Recipharm  Samsung Biologics  Sharp Services  Siegfried  Syngene  Takara Bio  Wacker Biotech  Wockhardt  WuXi Biologics Table of Contents 1. PREFACE 2. EXECUTIVE SUMMARY 3. INTRODUCTION 4. ASEPTIC FILL FINISH SERVICE PROVIDERS LANDSCAPE 5. BIOLOGICS FILL / FINISH SERVICE PROVIDERS LANDSCAPE 6. SMALL MOLECULE FILL / FINISH SERVICE PROVIDERS LANDSCAPE 7. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA 8. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN EUROPE 9. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC 10. PARTNERSHIPS AND COLLABORATIONS 11. MARKET SIZING AND OPPORTUNITY ANALYSIS 12. CASE STUDY: ROBOTICS IN PHARMACEUTICAL PACKAGING 13. CASE STUDY: READY-TO-USE PACKAGING COMPONENTS FOR ASEPTIC FILL / FINISH 14. CONCLUDING REMARKS 15. EXECUTIVE INSIGHTS 16. APPENDIX 1: TABULATED DATA 17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS To view more details on this report, click on the link https://www.rootsanalysis.com/reports/aseptic-fill-finish-market.html You may also be interested in the following titles: Cannabis Testing Market Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain Global Gene Switch Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #asepticfillfinish #asepticfilling #asepticmanufacturing #MarketResearch #MarketInsights

mRNA Synthesis and Manufacturing Services market Research Report by 2022, Forecast till 2035 Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the mRNA synthesis and contract manufacturing service providers Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Synthesis and Manufacturing Services Market (2nd Edition), 2022–2035” The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes  A general overview of mRNA, highlighting details on its structure, the evolution of mRNA vaccines, manufacturing processes and commonly outsourced manufacturing operations.  A detailed assessment of the overall market landscape of the companies offering mRNA custom synthesis services.  A detailed competitiveness analysis of mRNA custom synthesis service providers.  A comprehensive assessment of the overall market landscape of mRNA contract manufacturing service providers, based on several relevant parameters.  An in-depth company competitiveness analysis of mRNA contract manufacturing service providers based in North America, Europe and Asia-Pacific.  A detailed overview of the current market landscape of kits available for synthesis of research grade mRNA.  A detailed product competitiveness analysis of the mRNA synthesis kits.  Elaborate profiles of key players engaged in the synthesis and manufacturing of mRNA (shortlisted based on strength of service portfolio).  Detailed profiles of the key mRNA synthesis kit providers (shortlisted based on strength of product portfolio).  A detailed assessment of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines.  An insight analysis of the recent partnerships inked between stakeholders engaged in this domain from 2014-2022  An in-depth analysis of over 35 mRNA-based therapeutics / vaccines developers that are likely to partner with mRNA contract manufacturing service providers.  A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021)  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Product  Drug substances (APIs)  Drug products (FDFs)  Application Area  mRNA-based vaccines  mRNA-based therapeutics  Therapeutic Area  Infectious diseases  Oncological disorders  Other diseases  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa  Rest of the World Key companies covered in the report.  Aldevron  APExBIO  Biomay  bioSYNTHESIS  CELLSCRIPT  eTheRNA  Eurogentec  Jena Biosciences  New England Biolabs  Thermo Fisher Scientific  TriLink BioTechnologies To view more details on this report, click on the link https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html You may also be interested in the following titles: Buffer Preparation Market Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space Medical Device Coatings Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #mRNAsynthesisservices #mRNAsynthesisandmanufacturingservices #mRNAbasedproducts #MarketResearch #MarketInsights

Lipid Nanoparticles in Drug Delivery Market Trends, Analysis by 2035 Get more details on the Lipid Nanoparticles in Drug Delivery Market report https://www.rootsanalysis.com/reports/lipid-nanoparticles-ip-landscape.html

PRE-ENGINEERED, MODULAR FACILITIES HAVE EMERGED AS A VERSATILE SOLUTION FOR INDUSTRY STAKEHOLDERS IN PURSUIT OF FLEXIBLE MANUFACTURING SOLUTIONS Modular facilities are prefabricated buildings that are built using multiple sections, often known as modules. Primarily, the key difference between these and conventional buildings is the fact that modular constructs are designed, engineered and manufactured off-site, and later delivered to the intended site of use for final installation. It is worth noting that, in order to ensure that all critical systems are precisely configured, compliant to existing guidelines and fully operational, the modules are tested before shipping. Even though the concept of using modular manufacturing facilities in the pharmaceutical industry is not new, in recent years, it has witnessed renewed interest from several industry players. The increasing demand for improved processes and production facilities that are capable of handling multiple product types, as well as the shift towards manufacturing of smaller batches of drugs, in case of personalized therapies or candidates targeting rare diseases, are some of the key driving forces for the growing popularity of modular manufacturing plants in the pharmaceutical industry. Modular biomanufacturing includes division of individual production processes, such as fermentation, purification and formulation, into separate modules that can be easily assembled and disassembled, allowing for flexibility and scalability. In addition, modular manufacturing allows the use of smaller-scale production units, which can be more flexible and responsive to dynamic market demands. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/178/request-sample.html As indicated earlier, modular construction is a process wherein factory-produced, pre-engineered building units, which are constructed offsite under controlled plant conditions, are assembled on site to construct the final structure. It is worth mentioning that such buildings use the same material and designed according to the same codes and standards established for conventionally built structures. There are different types of modules used for construction of buildings. Examples of various modular constructs include 4-sided modules, partially open-sided (corner-supported) modules, mixed modules and planar floor cassettes, modules supported by a primary structural frame, non-load bearing modules, stair modules, skid-mounted process equipment modules, plug and play pods, and balconies and atria. In recent years, the focus of the pharmaceutical industry has shifted from mass production of blockbuster drugs for large patient populations to small batch production of personalized drugs targeting specific subpopulations of patients. Modular facilities were first introduced to the pharmaceutical market at a time when the mass production of tablets and capsules for large patient population was the norm; one of first products to be manufactured in such facilities was statins (prescribed to lower cholesterol). With the advent of generic copies of billion-dollar blockbuster drugs, targeting major disease indications, drug manufacturers are focusing on developing lower doses of highly potent biopharmaceutical drugs for targeted treatments. This shift has resulted in the segregation of large populations of patients into smaller, more specific sub-groups. Moreover, there is immense pressure on drug manufacturers to market novel drugs as soon as possible, before patent expiry. Increased pressure to expedite time to market, coupled with the need to decrease operating costs and increase manufacturing efficiencies, have amplified the value of smaller production facilities, which are more efficient and flexible. These market developments have made modular facilities more attractive to drug manufacturers today, as these facilities can quickly switch between multiple drugs, enabling formulation and packaging in multiple formats, such as solid, liquid, semi-solid and parenteral dosage forms. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/modular-manufacturing-market/178.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Smart Labels Market: Industry Trends and Global Forecasts, 2022-2035 2. AI-based Digital Pathology / AI Pathology Market: Industry Trends and Global Forecasts, 2022-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

The global cell cytometry market is anticipated to grow at a CAGR of ~10%, till 2035, claims Roots Analysis In order to accommodate the growing demand for higher accuracy, greater resolution and improved sensitivity in analytical processes, various industry stakeholders are engaged in the development of novel cytometry platforms with advanced features. Roots Analysis has announced the addition of “Global Cell Cytometry Market: Focus on High Throughput Flow Cytometry and Image Cytometry, 2022-2035” report to its list of offerings. Novel cell cytometry platforms has emerged to be the crucial analytical and visualization tools with applications across various areas, such as immunology, molecular biology, cancer biology and infectious disease monitoring. As a result, developers are currently engaged in the development of technologically advanced cell cytometry platforms that offer better throughput and accuracy. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/cell-cytometry-market/request-sample.html Key Market Insights Currently, more than 180 high throughput flow cytometry and image cytometry platforms are available in the market Majority (92%) of the high throughput flow cytometers are cell analyzers. Of these, ~40% of the devices operate at a throughput rate of 4 to 15 wells per minute. Similarly, majority (~50%) of the image cytometers can operate as both cell analyzers and cell sorters. Of these, 90% of the devices offer qualitative analysis. Presently, more than 25 developers are engaged in the development of cell cytometers, globally Notably, around 40% of the developers that offer high throughput flow cytometers are very large players (having more than 5,000 employees). In addition, 45% of the image cytometer developers were established post 2000. Of these, 75% of the players are headquartered in North America. Partnership activity in the global cell cytometry market has increased at steady rate, between 2017 and 2021 The maximum number of partnerships were established in 2021. Majority of the instances captured in the report were acquisitions and distribution agreements (25%, each). In addition, 75% of the deals have been inked by players headquartered in North America. 180+ USD million has been invested by various private and public investors in this domain, since 2017 Specifically, in 2020, the players raised over USD 125 million. It is worth noting that, majority (around 75%) of the investments were made in the form of venture capital rounds. Interestingly, around 45%of the funding instances were reported by mid-sized players (51 to 500 employees). Close to 35 global events related to cell cytometry have been organized, since 2018 Majority of the global events related to cell cytometry include webinars (over 40%) and conferences (~35%). It is worth highlighting that the main agenda of these events was to discuss the advantages of novel cell cytometers and their potential applications. ~500 patents have been granted / filed for cell cytometers, since 2020 70% of these were patent applications; Of these, close to 50% of the patents have been filed in 2021. It is worth noting that 45% of the patents related to cell cytometry were filed / granted in China alone, followed by US (~30%). The overall market is anticipated to grow at a CAGR of ~10%, during the period 2022-2035 North America and Europe are anticipated to capture around 35% of the market share, by 2035. In terms of types of cytometers, the image cytometers are expected to occupy a larger share (more than 55%) of the overall market in 2035. For additional details, please visit https://www.rootsanalysis.com/reports/cell-cytometry-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Smart Labels Market: Industry Trends and Global Forecasts, 2022-2035 2. AI-based Digital Pathology / AI Pathology Market: Industry Trends and Global Forecasts, 2022-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com